DEERFIELD, Ill.--(BUSINESS WIRE)--Lundbeck Inc., a wholly owned subsidiary of H. Lundbeck A/S in Denmark (LUN: Copenhagen Stock Exchange), announced today that ATryn ® (Antithrombin [Recombinant]) is ...

When to treat patients with heparin and when to treat using an antithrombin concentrate; Why it is important to aggressively treat patients with type one antithrombin deficiency who have already ...

The US Food and Drug Administration today approved the first-ever drug manufactured via a genetically engineered animal, opening the door for the wider use of such methods for producing drugs in the ...

INNOVANCE Antithrombin assay is a cutting-edge, ready-to-use chromogenic reagent for the automated determination of antithrombin (AT) activity. It is highly accurate even at low activity levels and ...

In June 2021, Kenneth A. Bauer, MD, from Beth Israel Deaconess Medical Center and professor of medicine at Harvard Medical School, spoke with Healio about the diagnosis and treatment of hereditary ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Endpoint Health, Inc., a precision-first TM therapeutics company dedicated to addressing urgent needs in immune-driven critical and chronic illnesses, today ...